Petro Rabigh seals partnership with Indian group Rossari
RIYADH, 3 days ago
Rabigh Refining & Petrochemical Company (Petro Rabigh), a joint venture between Saudi oil giant Aramco and Sumitomo Chemical, has entered into an agreement with India-based Rossari International for the development of propoxylates and ethoxylates manufacturing in Rabigh, Saudi Arabia.
Headquartered in Mumbai, Rossari International Limited is a major chemical manufacturing company engaged in the production of specialty enzymes and chemicals for use in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries.
This collaboration is a key step in strengthening Saudi Arabia’s specialty chemicals industry, supporting local production, reducing import dependency, and fostering innovation in critical sectors such as construction and personal care, stated Petro Rabigh in its LinkedIn post.
Aligned with the Saudi Vision 2030, the initiative will contribute to the Kingdom’s industrial self-sufficiency and economic growth, it stated.
This strategic partnership will see the combination of leading Swiss multinational company Sika’s advanced technologies with Rossari’s specialised capabilities to develop quality concrete additives and admixtures.
"Together, we are fostering Saudi Arabia’s Vision 2030 and Sika’s Strategy 2028, driving sustainable growth and innovation in the region’s construction sector," remarked Ali Hakami, the General Manager at Sika.
In another development, Petro Rabigh clinched a deal with Saudi Aajal Company to explore the establishment of factories for the production of synthetic pharmaceutical intermediaries (SPIs) and active pharmaceutical ingredients (APIs) in Rabigh.
The MoU was signed under the auspices of the Saudi Ministry of Energy.
This collaboration aims to enhance the kingdom's pharmaceutical security and reduce dependence on imports, in line with Vision 2030 by supporting local production and promoting innovation in the healthcare sector, said the top chemical company.
The project also contributes to achieving the objectives of diversifying the economy and improving public health services, it added.In another development, Petro Rabigh clinched a deal with Saudi Aajal Company to explore the establishment of factories for the production of synthetic pharmaceutical intermediaries (SPIs) and active pharmaceutical ingredients (APIs) in Rabigh.
The MoU was signed under the auspices of the Saudi Ministry of Energy.
This collaboration aims to enhance the kingdom's pharmaceutical security and reduce dependence on imports, in line with Vision 2030 by supporting local production and promoting innovation in the healthcare sector, said the top chemical company.
The project also contributes to achieving the objectives of diversifying the economy and improving public health services, it added.-In another development, Petro Rabigh clinched a deal with Saudi Aajal Company to explore the establishment of factories for the production of synthetic pharmaceutical intermediaries (SPIs) and active pharmaceutical ingredients (APIs) in Rabigh.
The MoU was signed under the auspices of the Saudi Ministry of Energy.
This collaboration aims to enhance the kingdom's pharmaceutical security and reduce dependence on imports, in line with Vision 2030 by supporting local production and promoting innovation in the healthcare sector, said the top chemical company.
The project also contributes to achieving the objectives of diversifying the economy and improving public health services, it added.-TradeArabia News Service
